# A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

> **NCT06234423** · PHASE1 · RECRUITING · sponsor: **OnCusp Therapeutics, Inc.** · enrollment: 263 (estimated)

## Conditions studied

- Ovarian Cancer
- Solid Tumor

## Interventions

- **DRUG:** CUSP06

## Key facts

- **NCT ID:** NCT06234423
- **Lead sponsor:** OnCusp Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-09
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-10-31
- **Target enrollment:** 263 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06234423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06234423, "A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06234423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*